Rosetta Biosoftware Releases the Rosetta Elucidator® System Version 3.2
December 3, 2008
SEATTLE--Rosetta Biosoftware, a global leader in life sciences informatics solutions, today announced the availability of the Elucidator system version 3.2, with major enhancements for support of SILAC and 14N/15N labeling and phosphoproteomics. The expanded suite of features empowers scientists with new workflows for biomarker discovery, verification and validation in basic and translational research. The Elucidator [...]
December 2, 2008
SHANGHAI, China & CARLSBAD, Calif.--Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE - News), a provider of innovative life science research and discovery solutions, today announced that the Chinese government and two leading food manufacturers are implementing its mass spectrometry-based technologies for food analysis as part of efforts to identify and contain the spread of [...]
2830 ZT Wafer Analyzer launch at SEMICON Japan
December 2, 2008
PANalytical (Almelo, the Netherlands) will launch its new 2830 ZT Wafer Analyzer at SEMICON Japan 2008, 3-5 December. The 2830 ZT offers the ultimate capability for simultaneous non-contact determination of layer thickness and composition. Designed specifically for the industry, it provides manufacturers with a powerful tool for achieving the tightest process monitoring throughout the entire [...]
December 2, 2008
PENZBERG, Germany--Following the launch of the xCELLigence RTCA SP Instrument in June, Roche Applied Science has introduced the new xCELLigence RTCA MP Instrument. In comparison with the RTCA SP, the new RTCA MP Instrument has a higher throughput capacity and it is more versatile which enables application on a wider range of experimental set-ups. The [...]
Decision Biomarkers Inc Announces Formation of Scientific Advisory Board
December 2, 2008
WALTHAM, Mass., Dec 02, 2008 -- Decision Biomarkers Inc, a leading developer of protein biomarker analysis systems for pharmaceutical research and development, today announced the formation of a Scientific Advisory Board consisting of internationally renowned scientists and physicians at the forefront of biomarker and clinical research. The Scientific Advisory Board includes: -- Daniel W. Chan, [...]
Symyx Registration 1.5 Software Provides Out-of-the-Box Chemical Data Management
December 2, 2008
Expands Compound Registration Options, Integrates Chemical and Biological Data SANTA CLARA, CA--Dec 2, 2008 -- Symyx Technologies, Inc. (NasdaqGS:SMMX - News) today announced the availability of Symyx Registration 1.5. This major new release offers R&D organizations of all sizes a flexible, fully featured, Isentris-based approach to building and managing consistent, searchable, and shareable corporate compound [...]
Fluxion Biosciences Signs New Distributor for Benelux and Scandinavia
December 2, 2008
Westburg BV to Distribute BioFlux Line of Live Cell Imaging Products San Francisco, Calif. (December 2, 2008) - Fluxion Biosciences announced today an exclusive distribution agreement with The Netherlands-based Westburg BV. Westburg BV will handle sales and service of Fluxion's BioFlux research tools for live cell image analysis in Belgium, The Netherlands, Luxembourg, Denmark, Finland, [...]
December 2, 2008
Will offer proteomic tests to identify Alzheimer's and Parkinson's disease OMAHA, Neb. and HOUSTON, Dec. 2 -- Transgenomic, Inc. (OTC Bulletin Board: TBIO - News) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM - News) today announced that Transgenomic has signed a letter of intent to acquire exclusive rights for Power3 Medical's Neurodegenerative Biomarkers, [...]
December 2, 2008
ST. JOSEPH, Mich., Dec. 2 -- GeneGo, Inc., the leading systems biology tools company, announced today that Burnham has become a certified GeneGo Center of Excellence. Burnham researchers will have institution-wide access to GeneGo's MetaCore data analysis suite, training and advanced support. The Burnham institute is a world-class biomedical research facility running multiple OMICs experimental [...]
BioTrove, Gene Express to Co-Market Novel Standardized Genetic Profiling Test
December 2, 2008
BioTrove Inc. and Gene Express, Inc. today announced an exclusive co-marketing agreement to test market a standardized genetic profiling test for indicators of lung cancer risk. Supported by a two-year National Institutes of Health (NIH) grant, the new profiling test combines BioTrove’s OpenArray® nanofluidic polymerase chain reaction (PCR) technology platform, Gene Express standards for accurate [...]

